SCHEMBL7375651

SCHEMBL7375651

c1cnc2ccc3c(c2c1)NCC3

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
KDM4E B2RXH2 1/20 0.52
CYP3A4 P08684 2/20 0.43
LMNA P02545 3/20 0.42
HIF1A Q16665 2/20 0.42
BLM P54132 2/20 0.42
MEN1 O00255 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.38
ERN1 O75460 1/20 0.37
TSHR P16473 2/20 0.36
NFKB1 P19838 1/20 0.36
THPO P40225 1/20 0.36
CYP11B2 P19099 2/20 0.36
NCOA1 Q15788 2/20 0.36
ADRB2 P07550 1/20 0.35
NCF1 P14598 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6764794 0.90 MAPT (0.48) MAPTKDM4ECYP3A4LMNAHIF1A
SCHEMBL1770055 0.79 KDM4E (0.41) MAPTKDM4ESMN1; SMN2ERN1ADRB2
SCHEMBL17375503 0.77 MAPT (0.46) MAPTKDM4ECYP3A4LMNAHIF1A
SCHEMBL13154670 0.76 CHRNB2 (0.33) KDM4ECYP3A4CYP1A2
SCHEMBL13154669 0.75 PKM (0.34)
SCHEMBL13154673 0.74 ADRA2A (0.36) MAPTKDM4ECYP3A4LMNABLM
SCHEMBL27896391 0.74 MAPT (0.50) MAPTKDM4ECYP3A4LMNAHIF1A
SCHEMBL634543 0.72 HSD17B10 (0.42) CYP3A4HIF1ATSHRNFKB1NCF1
SCHEMBL31668742 0.72 HSD17B10 (0.42) CYP3A4HIF1ATSHRNFKB1NCF1
SCHEMBL13154645 0.71 LMNA (0.52) MAPTKDM4ECYP3A4LMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820316-B Chiral indolo-dihydropyridoindole compound and synthesis method thereof 江苏师范大学 2024-06-28 CN claimed
CN-117820316-A Chiral indolo-dihydropyridoindole compound and synthesis method thereof 江苏师范大学 2024-04-05 CN claimed
JP-51118800-A None JP disclosed
JP-51118798-A None JP disclosed
JP-51118797-A None JP disclosed
JP-51118799-A None JP disclosed
CN-117820316-B Chiral indolo-dihydropyridoindole compound and synthesis method thereof 江苏师范大学 2024-06-28 CN disclosed
CN-117820316-B Chiral indolo-dihydropyridoindole compound and synthesis method thereof 江苏师范大学 2024-06-28 CN disclosed
US-11980086-B2 Use of transition metal carbene complexes in organic light-emitting diodes (OLEDs) UDC IRELAND LIMITED (IE) 2024-05-07 US disclosed
CN-117820316-A Chiral indolo-dihydropyridoindole compound and synthesis method thereof 江苏师范大学 2024-04-05 CN disclosed
CN-117820316-A Chiral indolo-dihydropyridoindole compound and synthesis method thereof 江苏师范大学 2024-04-05 CN disclosed
WO-2002036113-A1 COMPOSITION COMPRISING: SEROTONIN RECEPTOR ANTAGONISTS (5HT-2, 5HT-3) AND AGONIST (5HT-4) RESPIRATORIUS AB (SE) 2002-05-10 WO disclosed
US-5268472-A Monopersulfate salt AUSIMONT S.P.A. (IT) 1993-12-07 US disclosed
EP-0340755-B1 MONOPERSULFATES OF NITROGEN CONTAINING HETEROCYCLIC (POLY)PERCARBOXYLIC ACIDS AUSIMONT S.p.A. (IT) 1993-09-01 EP disclosed
EP-0340755-A1 Monopersulfates of nitrogen containing heterocyclic (poly)percarboxylic acids AUSIMONT S.p.A. (IT) 1989-11-08 EP disclosed
US-4091102-A Anti-depressant trans-hexahydropyrido[3,4-b]indoles ENDO LABORATORIES, INC. (US) 1978-05-23 US disclosed
JP-S51118797-A METHOD FOR PREPARING PYRIDOINDOLE AND AZEPINOINDOLE DERIVATIVES SANKYO CO LTD 1976-10-18 JP disclosed
JP-S51118800-A METHOD FOR PREPARING PYRIDOINDOLE DERIVATIVES SANKYO CO LTD 1976-10-18 JP disclosed
JP-S51118798-A METHOD FOR PREPARING PYRIDOINDOLE DERIVATIVES SANKYO CO LTD 1976-10-18 JP disclosed
JP-S51118799-A METHOD FOR PREPARING PYRIDINDOLE DERIVATIVES SANKYO CO LTD 1976-10-18 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11980086-B2 Use of transition metal carbene complexes in organic light-emitting diodes (OLEDs) OCIAD2, OCIAD1, ICOSLG MAPT 414/4885KDM4E 4325/4885CYP3A4 711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.